Pharmacy Report Archives - Page 49 of 148 - Becker's Hospital Review

Appeals court sides with 340B contract pharmacies | Amazon to deliver Zepbound | Weight loss drug efficacy, compared | Presbyterian CEO to retire | Drug shortages group seeks leader

Becker's Pharmacy Report is a top resource for healthcare leaders and one of our most-read newsletters. If this is in your “promotions” folder, please drag it to your regular inbox so you can receive future updates. March 13, 2024 BHR…

340B hospitals saved $30B in 5 years | Weight loss drugs bolster transplants | Resistance grows in common HIV drug | Mark Cuban's $141K oversight | 79 top hospitals for patients: Healthgrades

Becker's Pharmacy Report is a top resource for healthcare leaders and one of our most-read newsletters. If this is in your “promotions” folder, please drag it to your regular inbox so you can receive future updates. March 12, 2024 BHR…

Syphilis drug shortage persists | Wegovy secures 2nd indication | Mark Cuban's startup: 2 years later | 3 top safety issues in pharmacies: ECRI | Pharmacists address second victim syndrome

Becker's Pharmacy Report is a top resource for healthcare leaders and one of our most-read newsletters. If this is in your “promotions” folder, please drag it to your regular inbox so you can receive future updates. March 11, 2024 BHR…

Mark Cuban's drug co. nets 1st system partner | 10 drugs poised to be top-sellers | Lab finds carcinogens in acne products | 10 systems seeking pharmacy leaders | The 'right time' for retirement

March 7, 2024 BHR Newsletter 1. 10 drugs poised to be best-sellers in 2024 Full story 2. Mark Cuban's drug company partners with 1st health system Full story 3. Best, worst states to be rich Full story 4. 90 patients…

Mark Cuban to start making 2 drugs this week | Man OK after 217 COVID shots | 8 Ozempic updates | US launches Rx pricing task force | RSV vaccine: 5 safety notes

March 6, 2024 BHR Newsletter 1. 8 Ozempic updates Full story 2. Mark Cuban's pharma company to start manufacturing 2 drugs this week Full story 3. Man got 217 COVID shots — here's what happened Full story 4. Hospitals are…

Ozempic cuts risk of kidney problems | Hospital pharmacies request paused audits amid Change fallout | Systems magnify weight loss programs | Pharmacy CEO sentenced in $40M fraud case

March 5, 2024 BHR Newsletter 1. Health systems double down on weight loss programs Full story 2. Ozempic cuts risk of kidney problems in diabetes patients: New data Full story 3. Drugmakers send CMS counteroffers in fair price negotiations Full…

CVS, Walgreens to soon sell abortion pills, OTC birth control | RSV shots might be tied to rare condition | Overused cancer drug costs US $43M per year | CVS settles 27 understaffing cases for $1.5M

March 4, 2024 BHR Newsletter 1. CVS, Walgreens to begin selling abortion pills Full story 2. Retail pharmacies to sell OTC birth control within weeks Full story 3. Where medication abortion is, is not legal Full story 4. Adventist's reenvisioned…

Weight loss drugs bulk up economies | 1 in 3 local pharmacies to close in 2024: Survey | Tetanus vaccine shortage looms | 10 systems seeking pharmacy leaders | Are 8 a.m. meetings back?

February 29, 2024 BHR Newsletter 1. Weight loss drugs wrinkle economies worldwide Full story 2. CDC anticipates shortage of certain tetanus vaccines in 2024 Full story 3. 1 in 3 independent pharmacies to close this year: Survey Full story 4.…

Ozempic's potential rival | PBM probe stalls as AGs demand reforms | 2 drug candidates to know | Neb. hospital fires CEO | Cuban's pharmacy adds 21st branded drug

February 28, 2024 BHR Newsletter 1. A weight loss drug candidate could rival Ozempic Full story 2. PBMs not complying with federal probe: FTC Full story 3. State attorneys general call for federal PBM reforms Full story 4. 90 patients…

1st state OKs drug price ceiling | FDA urged to address Singulair controversy | Surgery surpasses drug outcomes for diabetes | Where Ozempic, AI + layoffs merge | 46 healthcare jobs, ranked

February 27, 2024 BHR Newsletter 1. Surgery better for diabetes than medical, lifestyle changes, 4 systems find Full story 2. New York asks FDA to address Singulair controversy Full story 3. For 1st time, state board sets a drug price…